We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Advancing Care and Improving Survival for Patients with HER2-Positive Breast Cancer
Terran Sims, MSN, ACNP-C, CNN, COCN-C
Jeremy Force
Sorting Through the Complexities of Managing Metastatic Colorectal Cancer: Strategies for Individualizing Treatment
Robert Lentz, MD
Application of Motivational Interviewing and Shared Decision-making Techniques in Obesity Management
Donna Ryan, MD
Daniel Zalinov, PA-C
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Building a Comprehensive Obesity Care Clinic
Caroline M. Apovian, MD, FTOS
W. Scott Butsch, MD, MSc
Treating Obesity as a Chronic Disease
Susan M. Tiso, DNP, APRN, FNP-BC, FAANP
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
Jonathan D. Schoenfeld, MD, MPhil, MPH
Robert L. Ferris, MD, PhD
Accelerating Evidence-Based Care in LA SCCHN
Ezra Cohen, MD, FRCPSC, FASCO
Sue S. Yom, MD, PhD
Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC
Heather Wakelee, MD, FASCO
Lyudmila Bazhenova, MD
RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic Breast Cancer
Christopher M. Gallagher, MD
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
RWE Where RCTs Fall Short: Optimizing Frontline Treatment of HR+/HER2- Metastatic Breast Cancer
Adam Brufsky, MD, PhD
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Unlocking Insights for Underrepresented Patients: The Role of Real-World Evidence in Addressing Limitations of CDK4/6 Inhibitor RCTs
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education